Clinical trial
Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intubation-free Survival in Acute Hypoxemic Respiratory Failure: the TRIPOD Randomized Clinical Trial
NCT06795971 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intubation-free Survival in Acute Hypoxemic Respiratory Failure: the TRIPOD Randomized Clinical Trial
- Lead sponsor
- Southeast University, China
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 23, 2025
- Completion date
- December 31, 2027
- Enrollment
- 1,300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute hypoxemic respiratory failure, continuous positive airway pressure (cpap), high-flow nasal oxygen therapy, noninvasive ventilation